Waitr (ASAP) News and press releases

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

31 Jan 23

Movers

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

25 Jan 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

25 Jan 23

Movers

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

25 Jan 23

Movers

Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

25 Jan 23

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a leading transportation and industrial equipment provider.

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

24 Jan 23

Movers

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

23 Jan 23

Movers

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

20 Jan 23

Movers

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

17 Jan 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.

Why First Wave BioPharma Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

17 Jan 23

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Celyad Oncology SA (NASDAQ: CYAD) rose 221.7% to $2.57 in pre-market trading after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

13 Jan 23

Movers

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

12 Jan 23

Movers

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

6 Jan 23

Movers

11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

4 Jan 23

Movers